Drug recall D-1436-2014

Class III Terminated reported Jul 23, 2014

Product

Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58

Reason for recall

Failed Impurities/Degradation Specifications: out of specification impurity test results.

Lots and codes

Lot 3805324A Exp. 11/14

Recall details

Recalling firm
Teva Pharmaceuticals USA, North Wales, PA
Quantity
1104 blister packs
Distribution
Nationwide
Type
Voluntary: Firm initiated
Recall initiated
June 17, 2014
Terminated
March 9, 2015

Related products